No statistically significant differences were observed between the EEF1G expression groups in terms of age at diagnosis, menopausal status, BMI, tumor size, nodal status, tumor subtype, clinical stage, PR status, HER‐2 status, and Ki‐67. Here, EEF1G is linked to neoplasm.